4-[3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoi c acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor α agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 12, 2000, Pages 1311-1313

  Dawson, Marcia I ^a   Jong, Ling ^b   Hobbs, Peter D ^b   Xiao, Dongmei ^c   Feng, Kai Chia ^a   Chao, Wan ru ^b   Pan, Chin ^a   Fontana, Joseph A ^d   Zhang, Xiao kun ^c  

^a Palo Alto Institute of Molecular Medicine   (United States)

^b SRI INTERNATIONAL   (United States)

^c BURNHAM INSTITUTE   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROTINOID; BENZOIC ACID DERIVATIVE; HETEROCYCLIC COMPOUND; RETINOIC ACID; RETINOID X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN CELL; MONKEY; NONHUMAN; STRUCTURE ANALYSIS;

BENZOATES; HETEROCYCLIC COMPOUNDS; HUMANS; NAPHTHALENES; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034686419     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00244-4     Document Type: Article

References (16)

1. Loeliger P., Bollag W., Mayer H. Eur. J. Med. Chem.-Chim. Ther. 15:1980;9.
2. Dawson M.I., Chan R.L.-S., Derdzinski K., Hobbs P.D., Chao W., Schiff L.J. J. Med. Chem. 26:1983;1653.
3. Lehmann J.M., Dawson M.I., Hobbs P.D., Husmann M., Pfahl M. Cancer Res. 51:1991;4804.
4. Nagpal S., Patel S., Jacobe H., DiSepio D., Ghosn C., Malhotra M., Teng M., Duvic M., Chandraratna R.A. J. Invest. Dermatol. 109:1997;91.
5. Shroot B., Michel S. J. Am. Acad. Dermatol. 36:1997;S96.
6. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. In The Retinoids. Biology, Chemistry, and Medicine; Sporn, M. B.; Roberts, A. B.; Goodman, D. S., Eds.; Raven: New York, 1994; pp 319-350.
7. Nagy L., Thomázy V.A., Shipley G.L., Fésüs L., Lamph W., Heyman R.A., Chandraratna R.A.S., Davies P.J.A. Mol. Cell. Biol. 15:1995;3540.
8. Bissonnette R.P., Brunner T., Lazarchik S.B., Yoo N.J., Boehm M.F., Green D.R., Heyman R.A. Mol. Cell. Biol. 15:1995;5576.
9. Wu Q., Dawson M.I., Zheng Y., Hobbs P.D., Agadir A., Jong L., Li Y., Liu R., Lin B., Zhang X.-K. Mol. Cell. Biol. 17:1997;6598.
10. Li Y., Dawson M.I., Agadir A., Li M.-O., Hobbs P.D., Zhang X. Int. J. Cancer. 75:1998;88.
11. Chao W., Hobbs P.D., Jong L., Zhang X., Dawson M.I. Cancer Lett. 115:1997;1.
12. Jong L., Lehmann J.M., Hobbs P.D., Harlev E., Huffman J.C., Pfahl M., Dawson M.I. J. Med. Chem. 36:1993;2605.
13. Canan Koch S.S., Dardashti L.J., Cesario R.M., Croston G.E., Boehm M.F., Heyman R.A., Nazdan A.M. J. Med. Chem. 42:1999;742.
14. Miyaura N., Suzuki A. Chem. Rev. 95:1995;2457.
15. Kagechika H., Kawachi E., Hashimoto Y., Shudo K. J. Med. Chem. 32:1989;834.
16. 2H).